Tidal Vision, a biotechnology company transforming critical industries with chitosan-based chemistries, announced the closing of an oversubscribed $140 million Series B financing round. This funding round exceeded its original target due to demand from strategically investors including Cambridge Companies SPG, Eni Next (the corporate venture arm of Eni S.p.A), Milliken & Company, KIRKBI Climate, Convent Capital, SWEN Capital Partners’ Blue Ocean Fund, MBX Capital, Oman Investment Authority’s IDO Investments, and more.
This funding advances Tidal Vision’s ability to continuously increase the performance, economics, and ease of adoption of chitosan-based solutions with greater production capacities and expanded research and development resources. And the company is building new infrastructure in Europe, Texas, and Ohio, further expanding its footprint.
The resources will also be invested in accelerating R&D in chitosan and adjacent technologies, adding to the company’s already impressive intellectual property portfolio. With a greater number of both commercial-scale and R&D facilities around the world, Tidal Vision will make chitosan-based solutions more accessible to customers globally.
KEY QUOTES:
“We are thrilled to have these strategically aligned capital partners onboard and supportive of accelerating our mission. We’ve already demonstrated it’s possible to make our biomolecular solutions outcompete. Now, we’re building infrastructure that’ll allow us to better serve customers who operate in critical industries providing the clean water, agriculture production, and materials necessary for everyday life.”
- Craig Kasberg, CEO of Tidal Vision
“We’re pleased to have led this $140 million Series B growth equity round for Tidal Vision. Tidal Vision is the global leader in chitosan extraction, modification, characterization, and commercial applications. These important investments will enable Tidal Vision to continue to apply these crucial scientific breakthrough technologies commercially across a variety of sectors.”
- Filipp Chebotarev, Managing Partner and Chief Operating Officer at Cambridge Companies SPG
